Galindo-García G, Galván-Plata ME, Nellen- Hummel H, Almeida-Gutiérrez E

Language: Spanish
References: 17
Page: 6-12
PDF size: 220.25 Kb.

ABSTRACT

Introduction: Stress hyperglycemia is the elevation of serum glucose found in a patient, once he is admitted in the hospital. The objective of this study was to evaluate the impact of admission serum glucose level in the outcome of noncritical hospitalized patients.
Methods: A prospective analytical cohort study was conducted in patients hospitalized in the Internal Medicine service of the Hospital de Especialidades, Centro Médico Nacional Siglo XXI (Instituto Mexicano del Seguro Social), from September 2011 to February 2012.
Results: We included 89 patients with serum glucose level ‹ 110 mg/dL (group A) and 90 patients with serum glucose › 110 mg/dL (group B). Diabetes mellitus was more frequent in group B (p ‹ 0.001). Glycosylated hemoglobin greater than 6.5 % was found in 36.4 % of the patients in group B and in 8.7 % in group A (p ‹ 0.001). Patients in group B had higher APACHE II score (p = 0.02) and worse in-hospital outcomes.
Conclusions: Stress hyperglycemia was associated with higher APACHE II score and more medical complications, such as sepsis, urinary tract infection, pneumonia and use of pressor amines. Mortality independent predictors were systemic arterial hypertension and APACHE II score.

REFERENCES

1. Pinheiro CP, Oliveira MD, Faro GB, Silva EC, Rocha EA, Barreto-Filho JA, et al. Prognostic value of stress hyperglycemia for in-hospital outcome in acute coronary artery disease. Arq Bras Cardiol. 2013;100(2):127-34.

2. Angeli F, Verdecchia P, Karthikeyan G, Mazzotta G, Del Pinto M, Repaci S, et al. New-onset hyperglycemia and acute coronary syndrome: a systematic overview and meta-analysis. Curr Diabetes Rev. 2010;6(2):102-10.

3. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87(3):978–82.

4. Manzanares W, Aramendi I. Hiperglucemia de estrés y su control con insulina en el paciente crítico: evidencia actual. Med Intensiva. 2010;34(4):273–81

5. Dungan KM, Braithwaite SS, Preiser JC. Stress hyperglycaemia. Lancet. 2009; 373(9677): 1798-807.

6. Stegenga ME, van der Crabben SN, Blümer RM, Levi M, Meijers JC, Serlie MJ, et al. Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fi brinolysis during human endotoxemia. Blood. 2008;112(1):82-9.

7. Kosiborod M, Rathore SS, Inzucchi SE, Masoudi FA, Wang Y, Havranek EP, et al. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation. 2005;111(23):3078-86.

8. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke. 2001;32(10):2426-32.

9. Paciaroni M, Agnelli G, Caso V, Corea F, Ageno W, Alberti A, et al. Acute hyperglycemia and early hemorrhagic transformation in ischemic stroke. Cerebrovasc Dis. 2009, 28(2):119-23.

10. Imran SA, Ransom TP, Buth KJ, Clayton D, Al- Shehri B, Ur E, et al. Impact of admission serum glucose level on in-hospital outcomes following coronary artery bypass grafting surgery. Can J Cardiol. 2010;26(3):151-4.

11. Baker EH, Janaway CH, Philips BJ, Brennan AL, Baines DL, Wood DM, et al. Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease. Thorax. 2006; 61(4):284-9.

12. Peralta G, Sanchez MB, Garrido JC, Ceballos M, Mateos F, Benito I, et al. Altered blood glucose concentration is associated with risk of death among patients with community-acquired Gram-negative rod bacteremia. BMC Infect Dis. 2010 Jun 22;10:181. [aprox. 9 pág.].

13. Barsheshet A, Garty M, Grossman E, Sandach A, Lewis BS, Gottlieb S, et al. Admission blood glucose level and mortality among hospitalized nondiabetic patients with heart failure. Arch Intern Med. 2006;166(15):1613-9.

14. Vivas D, García-Rubira JC, González Ferrer JJ, Nuñez-Gil I, del Prado N, Fernández-Ortiz A, et al. Valor pronóstico de la primera glucemia en ayunas en comparación con la glucemia al ingreso en pacientes con síndrome coronario agudo. Rev Esp Cardiol. 2008;61(5):458-64.

15. Verges B, Zeller M, Dentan G, Beer JC, Laurent Y, Janin-Manifi cat L. Impact of fasting glycemia on short term prognosis after acute myocardial infarction. J Clin Endocrinol Metab. 2007;92(6):2136-40.

16. Umpierrez GE, Smiley D, Zisman A, Prieto LM, Palacio A, Ceron M, et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes care. 2007;30(9):2181-6.

17. Leite SAO, Anderson RL, Kendall DM, Monk AM, Bergenstal RM. A1C predicts type 2 diabetes and impaired glucose tolerance in a population at risk: the community diabetes prevention project. Diabetol Metab Syndr. 2009;1(1):5. [aprox. 7 pág.].